In vitro SIT supplementation significantly inhibited the binding of prostate cancer cells to laminin and fibronectin, 2 important BM components, and attenuated the invasion and migration of tumor cells as shown in the transwell assay. The gene discussed is FN1; the disease is neoplasm.